biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > No posts for over a month

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Nov 10, 2023 12:41pm

101 Views

Post# 35728769

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:No posts for over a month

I'm not surprised that you would talk of a women as a victom of a man when for some couples there is equality where the best and the worst (for better or worse) are not words but are functional. My wife and I share the responsibilty.

But I understand that you have no such respect for women. I suppose you think they should be grateful for the life you think you are gracious enough to provide them.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec